http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63301870-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-22
filingDate 1988-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1915602d1080428fce7c36c7651c2a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70f2bb1eabeb7c7941c2a9bdc3b7ea52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a6f7ee0e6e15b4a561e40747094f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a283fded33e181355ff56abd77677ca
publicationDate 1988-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S63301870-A
titleOfInvention Pyridazinone derivative
abstract NEW MATERIAL:A compound expressed by formula I [R 1 is H, 2-propenyl, 1W4C alkyl; R 2 is H or 1W3C alkyl; X is Cl or Br; Y is H, nitro or NHR 3 (R 3 is H or 1W4C alkyl), or AR 4 (A is O or S; R 4 is 1W6C alkyl, 3W6C alkenyl, etc.; Z 1 is H or 1W4C alkyl, OR 6 (R 6 is H or 1W8C alkyl), halogen, etc.; Z 2 is Z 1 excluding H, etc.]. n EXAMPLE: 4-Chloro-5-( 3-n-butoxy-4-methoxybenzylamino )-6-ethoxy-3-(2H)pyrida zinone. n USE: A medicine. SRS-A antagonist. An active ingredient of medicine for preventing or treating disease caused by either one of leukotrikon C 4 , D 4 and E 4 or mixture thereof. n PREPARATION: A compound expressed by formula II (Ya is H, nitro, amino, OR 4 or halogen) is reacted with a compound expressed by formula III in a solvent, as necessary in the presence of a deacidificating agent to provide the compound expressed by formula I wherein Y is Ya. n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5202323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022502423-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5314883-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9116314-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5318968-A
priorityDate 1987-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3088338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407318370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425967596

Total number of triples: 31.